Source: JCO Global Oncology. Unidade: FMRP
Subjects: NEOPLASIAS PROSTÁTICAS, COMORBIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUZ, Murilo de Almeida et al. Consensus on prostate cancer treatment of localized disease with very low, low, and intermediate risk: a report from the first Prostate Cancer Consensus Conference for Developing Countries (PCCCDC). JCO Global Oncology, v. 7, p. 523-529, 2021Tradução . . Disponível em: https://doi.org/10.1200/GO.20.00515. Acesso em: 09 nov. 2024.APA
Luz, M. de A., Guimarães, G. C., Nardi, A. C., Pompeo, A. S. F. L., Sarkis, Á. S., Nowier, A., et al. (2021). Consensus on prostate cancer treatment of localized disease with very low, low, and intermediate risk: a report from the first Prostate Cancer Consensus Conference for Developing Countries (PCCCDC). JCO Global Oncology, 7, 523-529. doi:10.1200/GO.20.00515NLM
Luz M de A, Guimarães GC, Nardi AC, Pompeo ASFL, Sarkis ÁS, Nowier A, Pompeo ACL, Nardozza Júnior A, Adamy Júnior A, Reis RB dos. Consensus on prostate cancer treatment of localized disease with very low, low, and intermediate risk: a report from the first Prostate Cancer Consensus Conference for Developing Countries (PCCCDC) [Internet]. JCO Global Oncology. 2021 ; 7 523-529.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1200/GO.20.00515Vancouver
Luz M de A, Guimarães GC, Nardi AC, Pompeo ASFL, Sarkis ÁS, Nowier A, Pompeo ACL, Nardozza Júnior A, Adamy Júnior A, Reis RB dos. Consensus on prostate cancer treatment of localized disease with very low, low, and intermediate risk: a report from the first Prostate Cancer Consensus Conference for Developing Countries (PCCCDC) [Internet]. JCO Global Oncology. 2021 ; 7 523-529.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1200/GO.20.00515